Medical Device Penetration Testing Companies, FDA Submission-Ready
You are searching for a medical device penetration testing company because the FDA premarket guidance expects adversarial testing of the actual device (protocol interfaces, hardware debug ports, and the update mechanism) with results traceable into the risk file.
The labs below are verified on device-specific testing: instrumented protocol testing (BLE, proprietary serial, network), hardware-level attacks, and reports formatted for premarket submission rather than a generic web-app report.
What renders on this page
- ▸Matrix of labs with medical-device testing methodology tags (TIR57-aligned)
- ▸Hardware lab availability and test-rig capabilities
- ▸Direct "Request Secure RFP" form pre-wired to the medtech template
Generic penetration testing reports get kicked back
A submission needs findings mapped to device risks and mitigations in the SRMP, reviewers cross-read the test report against the threat model. Labs here document TIR57-aligned reporting and first-cycle acceptance records by submission type.
What medical device penetration testing company engagements typically cost, and what drives the price
No honest page quotes a single number, because the price of medical device penetration testing company work varies by scope. The drivers that move quotes are the number of devices and device families in scope, and whether the work is premarket (submission support) or postmarket (monitoring and patching), the maturity of your existing documentation, a draft SBOM and threat model cost less to review than to build from zero, and the stage of your FDA submission calendar, work compressed against a submission deadline is priced differently from work scheduled ahead of it. For real numbers, use the verified directory's rate data and from structured RFP responses with real quotes from device-security consultancies.
How long it takes
Premarket cybersecurity documentation typically runs alongside your regulatory timeline, not after it, SBOM and threat-model work starts with design inputs.
Penetration testing is bounded by test-unit availability and lab scheduling, not by the firm's calendar alone.
Postmarket vulnerability management is continuous by definition, the first engagement sets the monitoring rhythm.
What to prepare before you engage a firm
The firms you are about to compare will scope faster (and quote more accurately) if you arrive with your intended-use statement and device architecture documentation, a software bill of materials (SBOM), or a statement of where you stand on building one, any existing threat model or risk assessment artifacts, even drafts, and the regulatory pathway you are pursuing (510(k), De Novo, PMA) and where you are in it.
Common mistakes to avoid when choosing
treating cybersecurity documentation as a late submission-stage checkbox rather than a design-input activity
commissioning a penetration test before the threat model exists, testing against an unranked attack surface wastes budget
buying SBOM tooling without the engineering process to keep the SBOM current, an SBOM that goes stale at submission helps no one
What happens after you engage
A well-run medical device penetration testing company engagement follows a predictable arc: a gap assessment against FDA's premarket and postmarket cybersecurity guidance (and Section 524B requirements where they apply), then a documentation work plan sequenced against your submission calendar, then the technical work (threat modeling, testing, SBOM remediation) with evidence in the format reviewers expect, and finally submission support: reviewer-question responses and postmarket handoff. If a firm cannot describe this arc for your environment, that itself is a finding.
Frequently asked questions
When in development should pen testing happen?
Late enough that the architecture is real, early enough to fix findings without design churn, typically on design-freeze builds, with a retest window before submission. Labs listing retest SLAs in the directory make the timeline concrete.
How long does a device pen test take?
Commonly 2–6 weeks per device depending on interface count and hardware complexity. The RFP captures the interface inventory so scoping calls happen before contracts, not during them.
How much does medical device cybersecurity consulting cost?
Cost tracks device-family count, documentation maturity, and your submission stage, the three drivers above. The verified directory lists device-security consultancies with disclosed rate data where available, and structured RFP responses return real quotes for your specific device scope.
When in the device lifecycle should we engage a security firm?
Before the threat model is due as a design input, not at submission. Firms engaged early can shape the SBOM and threat-model work into the design process; firms engaged late can only document what already happened.